Open AccessAbstract CT187: Pembrolizumab and nanoparticle albumin bound paclitaxel (nab-paclitaxel) as salvage therapy for metastatic urothelial carcinoma (UC)
Author(s) -
Patrizia Giannatempo,
Daniele Raggi,
Elena Farè,
Laura Marandino,
Marco Bandini,
Maurizio Colecchia,
Filippo Pederzoli,
Giuseppina Calareso,
Russell Madison,
Francesco Monopoli,
Giusy Russo,
Roberto Ferrara,
Filippo de Braud,
Francesco Montorsi,
Andrea Necchi
Publication year - 2020
Publication title -
cancer research
Language(s) - English
Resource type - Conference proceedings
SCImago Journal Rank - 1.055
H-Index - 84
eISSN - 1538-7445
pISSN - 0008-5472
DOI - 10.1158/1538-7445.am2020-ct187
Subject(s) - medicine , neutropenia , metastatic urothelial carcinoma , clinical endpoint , progression free survival , febrile neutropenia , pembrolizumab , metastatic breast cancer , oncology , gastroenterology , adverse effect , paclitaxel , progressive disease , surrogate endpoint , surgery , urology , toxicity , cancer , clinical trial , chemotherapy , immunotherapy , breast cancer , urothelial carcinoma , bladder cancer